Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cilia- and flagella-associated protein 70 (CFAP70) is a structural protein enriched in motile cilia and sperm flagella, characterized by multiple tetratricopeptide repeat (TPR) domains that mediate protein–protein interactions[1][2]. CFAP70 localizes strongly to the axonemal cytoskeleton in cilia, where it acts as a regulatory component for the outer dynein arm (ODA) machinery, influencing the motility of cilia and flagella[1][2]. Knockdown or genetic disruption of CFAP70 leads to impaired ciliogenesis, decreased ciliary beating, disruption of axonemal structure, male infertility (due to flagellar biogenesis defects in spermatids), and hydrocephalus due to functional loss in brain cilia[2]. It interacts with the flagellar assembly machinery and stabilizes partner proteins such as QRICH2[2]. While not a classical drug target, pathogenic mutations in CFAP70 serve as important genetic markers for the diagnosis of certain syndromes of male infertility and ciliary disease[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cilia- and flagella-associated protein 70 (CFAP70).